The AZITROCIN brand, founded in 2002 (United States), from 1125 sister brands and 17477 competing brands. The AZITROCIN brand is owned by Pfizer Inc, a company listed in New York. AZITROCIN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(AZITROCIN)
over 5 years*
USD 18.24